- Home
- MREO vs SRTS Comparison
MREO vs SRTS Comparison
Compare MREO & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | SRTS |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 48.9M |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MREO | SRTS |
|---|---|---|
| Price | $0.34 | $3.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $1.96 | ★ $5.38 |
| AVG Volume (30 Days) | ★ 1.7M | 22.1K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $500,000.00 | ★ $27,482,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $41.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $2.66 |
| 52 Week High | $2.37 | $5.49 |
Technical Indicators
Market Signals| Indicator | MREO | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 54.00 | 42.40 |
| Support Level | $0.35 | $2.85 |
| Resistance Level | $0.35 | $3.30 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 47.31 | 13.33 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.